EPE Special Opportunities (ESO) Competitors GBX 140.60 -3.40 (-2.36%) As of 10/20/2025 06:14 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ESO vs. BBH, FTF, NUC, BRNA, MCP, BRSA, CRWN, IGC, GABI, and DUKEShould you be buying EPE Special Opportunities stock or one of its competitors? The main competitors of EPE Special Opportunities include Bellevue Healthcare (BBH), Foresight Enterprise VCT (FTF), Nucleus Financial Group (NUC), BlackRock North American Income Trust (BRNA), Martin Currie Asia Unconstrand Trust (MCP), BlackRock Sustainable American Income (BRSA), Crown Place VCT (CRWN), India Capital Growth (IGC), GCP Asset Backed Income (GABI), and Duke Capital (DUKE). These companies are all part of the "asset management" industry. EPE Special Opportunities vs. Its Competitors Bellevue Healthcare Foresight Enterprise VCT Nucleus Financial Group BlackRock North American Income Trust Martin Currie Asia Unconstrand Trust BlackRock Sustainable American Income Crown Place VCT India Capital Growth GCP Asset Backed Income Duke Capital EPE Special Opportunities (LON:ESO) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability. Do insiders and institutionals believe in ESO or BBH? 9.8% of EPE Special Opportunities shares are held by institutional investors. Comparatively, 13.6% of Bellevue Healthcare shares are held by institutional investors. 2.4% of EPE Special Opportunities shares are held by company insiders. Comparatively, 0.4% of Bellevue Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is ESO or BBH more profitable? Bellevue Healthcare has a net margin of 169.10% compared to EPE Special Opportunities' net margin of -10.57%. EPE Special Opportunities' return on equity of -0.41% beat Bellevue Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets EPE Special Opportunities-10.57% -0.41% 0.41% Bellevue Healthcare 169.10%-4.48%N/A Does the media prefer ESO or BBH? In the previous week, EPE Special Opportunities had 3 more articles in the media than Bellevue Healthcare. MarketBeat recorded 3 mentions for EPE Special Opportunities and 0 mentions for Bellevue Healthcare. EPE Special Opportunities' average media sentiment score of 1.87 beat Bellevue Healthcare's score of 0.00 indicating that EPE Special Opportunities is being referred to more favorably in the media. Company Overall Sentiment EPE Special Opportunities Very Positive Bellevue Healthcare Neutral Which has higher valuation and earnings, ESO or BBH? EPE Special Opportunities has higher revenue and earnings than Bellevue Healthcare. EPE Special Opportunities is trading at a lower price-to-earnings ratio than Bellevue Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEPE Special Opportunities-£5.88M-6.30£12.80M-£27.83-5.05Bellevue Healthcare-£46.85M-3.25-£16.23M-£26.22-4.90 SummaryEPE Special Opportunities beats Bellevue Healthcare on 7 of the 12 factors compared between the two stocks. Get EPE Special Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for ESO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ESO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESO vs. The Competition Export to ExcelMetricEPE Special OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£37.01M£1.44B£4.83B£2.57BDividend YieldN/A4.72%4.41%5.38%P/E Ratio-5.05157.9170.37493.42Price / Sales-6.301,973.261,441.2398,772.65Price / Cash1.7960.4648.9327.90Price / Book0.431.353.508.07Net Income£12.80M£264.59M£1.22B£5.89B7 Day Performance1.88%-0.05%-0.31%-0.12%1 Month Performance3.07%0.01%0.81%1.07%1 Year Performance-8.89%8.01%38.64%126.15% EPE Special Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESOEPE Special OpportunitiesN/AGBX 140.60-2.4%N/A-8.1%£37.01M-£5.88M-5.05N/ANews CoveragePositive NewsBBHBellevue HealthcareN/AGBX 125.60-1.3%N/A-12.0%£148.90M-£46.85M-479.02N/AFTFForesight Enterprise VCTN/AGBX 46.80flatN/AN/A£148.25M£2.13M93.60N/ANUCNucleus Financial GroupN/AN/AN/AN/A£147.31M£51.81M46.71356BRNABlackRock North American Income TrustN/AN/AN/AN/A£147.22M£39.61M4.02N/APositive NewsMCPMartin Currie Asia Unconstrand TrustN/AN/AN/AN/A£145.58M£6.14M43.1321,000BRSABlackRock Sustainable American IncomeN/AN/AN/AN/A£145.23M£22.37M8.28N/ACRWNCrown Place VCTN/AGBX 28-2.4%N/A-8.2%£145.18M£5.95M1,564.25N/APositive NewsEarnings ReportGap DownIGCIndia Capital GrowthN/AGBX 170-0.6%N/A-9.1%£144.94M-£6.98M-1,706.8361Positive NewsGABIGCP Asset Backed IncomeN/AGBX 67flatN/A-13.4%£144.46M-£8.00M-2,803.35N/ADUKEDuke Capital2.5338 of 5 starsGBX 28-0.7%GBX 43.50+55.4%-15.4%£140.62M£6.40M6,222.22N/A Related Companies and Tools Related Companies BBH Competitors FTF Competitors NUC Competitors BRNA Competitors MCP Competitors BRSA Competitors CRWN Competitors IGC Competitors GABI Competitors DUKE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ESO) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EPE Special Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share EPE Special Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
